Uric acid‐lowering drug showed no clear difference in adverse events (withdrawals due to side effects) compared with placebo (low certainty).
It is very uncertain whether prefabricated foot orthoses changes withdrawal due to adverse events compared with shoes (very low certainty).
Prefabricated foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes; GRADE not reported.
The review found no eligible studies for this question.
It is very uncertain whether enteric‐release glyceryl trinitrate changes withdrawal due to adverse events compared with placebo (very low certainty).
Skim milk enriched with GMP/G600 showed no clear difference in study withdrawals due to adverse events compared with skim milk, plus lactose powder (low certainty).
It is very uncertain whether tricyclic antidepressant changes number of Withdrawals due to Adverse Events patient interview compared with control (very low certainty).
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
It is very uncertain whether antihypertensive therapy changes withdrawal due to adverse events compared with placebo or no treatment (very low certainty).
The review found no eligible studies for this question.
Drospirenone plus ethinylestradiol may leads to higher withdrawal due to adverse events compared with placebo (low certainty).
It is very uncertain whether one‐food elimination diet changes withdrawals due to adverse events compared with six‐food elimination diet (very low certainty).
Elemental formula supplements showed no clear difference in withdrawals due to adverse events compared with polymeric formula supplements (low certainty).
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes (low certainty).
Customised foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes (low certainty).
Benzbromarone may leads to lower withdrawal due to adverse events compared with probenecid (low certainty).
Benzbromarone showed no clear difference in withdrawal due to adverse events compared with allopurinol (low certainty).
It is very uncertain whether mepolizumab 10 mg/kg changes withdrawals due to adverse events at 8 weeks compared with mepolizumab 0.55 mg/kg (very low certainty).
It is very uncertain whether mepolizumab 2.5 mg/kg changes withdrawals due to adverse events at 8 weeks compared with mepolizumab 0.55 mg/kg (very low certainty).